PeerView Endocrinology CME/CNE/CPE Audio Podcast
Summary: PeerView Press is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
- Visit Website
- RSS
- Artist: PVI, PeerView Institute for Medical Education
- Copyright: 2006
Podcasts:
Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.
In this activity, an expert in painful DPN discusses differential diagnosis of the condition and management approaches in treatment-naïve patients as well as in individuals with established diagnosis.
Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.
In this activity, experts in the management of type 2 diabetes discuss aspects of novel glucose-lowering therapies in the overall context of optimal disease management.
Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.
In this activity, experts review the association between HIV disease, antiretroviral therapy, and the risk for metabolic dysfunction in patients with HIV. A review of the most appropriate management strategies for metabolic dysfunction in this patient population is featured.
CME/CE Information - Understanding Metabolic Dysfunction in HIV
In this activity, experts in the treatment of diabetes explore the use of incretin-based therapies in the management of this condition. An assessment of data from the 68th Scientific Sessions of the American Diabetes Association is featured.
Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file.
In this activity, an expert in the treatment of diabetes investigates the importance of addressing the many cardiometabolic risk factors that are present in patients with type 2 diabetes. The activity also features an analysis of the impact of newer antidiabetic agents, including incretin mimetics and DPP-IV inhibitors, on improving a number of these risk factors.
Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file.